4
Changes in Ownership
Processa Pharmaceuticals, Inc. Filed Acc 0001567619-23-000326
Options or other derivatives
- Chief Operating Officer acquired 106,648 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Floyd Robert Michael · Chief Operating Officer
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-12-31 | Grant or award : show line 1 in the form Restricted Stock Units | +10,851 | 344,531 | D |
| 2023-01-01 | Grant or award : show line 2 in the form Restricted Stock Units | +55,107 | 399,638 | D |
| 2023-01-01 | Grant or award : show line 3 in the form Restricted Stock Units | +40,690 | 440,328 | D |
Loading xslF345X03/doc1.xml…